Rheumatology · Chronic Pain Syndromes
The facts most likely to be tested
Fibromyalgia is a diagnosis of exclusion characterized by chronic widespread musculoskeletal pain lasting longer than three months.
Patients typically present with diffuse tenderness at multiple soft tissue sites without evidence of joint inflammation or synovitis.
The Widespread Pain Index (WPI) and Symptom Severity (SS) scale are the primary clinical tools used to establish the diagnosis.
Common comorbidities include fatigue, non-restorative sleep, cognitive dysfunction (fibro-fog), and mood disorders like depression or anxiety.
First-line pharmacologic therapy consists of tricyclic antidepressants (TCAs) like amitriptyline, or serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine or milnacipran.
Pregabalin is an FDA-approved gabapentinoid indicated for the management of fibromyalgia-associated pain.
Patient education and aerobic exercise are the first-line non-pharmacologic interventions and are essential for long-term management.
Vignette unlocked
A 38-year-old woman presents to the clinic complaining of generalized body aches and profound fatigue for the past 6 months. She reports that her pain is constant and affects both sides of her body, above and below the waist. Physical examination reveals multiple tender points upon palpation of the trapezius, gluteal, and lateral epicondyle regions, but there is no joint swelling, erythema, or warmth. Laboratory studies, including ESR, CRP, and ANA, are all within normal limits. She also reports difficulty concentrating and feeling unrefreshed after a full night's sleep.
What is the most appropriate initial pharmacologic treatment for this patient?
Duloxetine or Amitriptyline
The patient's presentation of chronic widespread pain with normal inflammatory markers is classic for fibromyalgia; SNRIs or TCAs are the first-line pharmacologic agents for symptom management.
Full handout
High yield triage
Etiology / Epidemiology
Predominantly affects middle-aged women (30-50 years). Pathophysiology involves central sensitization of pain pathways.
Clinical Manifestations
Characterized by widespread musculoskeletal pain and fibro fog. Patients exhibit allodynia and hyperalgesia.
Diagnosis
Diagnosis is clinical based on the Widespread Pain Index (WPI) and Symptom Severity (SS) scale.
Treatment
First-line pharmacotherapy includes Pregabalin or Duloxetine. Avoid opioids due to lack of efficacy.
Prognosis
Chronic condition with no cure; focus on multidisciplinary management to improve functional status.
Full handout
Epidemiology & Etiology
Occurs most frequently in women aged 30-50. Often triggered by physical trauma, surgery, or significant psychological stress. It is a disorder of pain processing rather than peripheral inflammation.
Pertinent Anatomy
Involves the central nervous system (CNS) rather than joints or muscles. Dysregulation of descending pain inhibitory pathways leads to heightened sensitivity.
Pathophysiology
Characterized by central sensitization, where the CNS amplifies pain signals. Patients show elevated levels of substance P in the cerebrospinal fluid. There is a documented imbalance of serotonin and norepinephrine neurotransmission.
Clinical Manifestations
Patients present with widespread pain lasting >3 months involving all four quadrants. Classic features include fibro fog (cognitive dysfunction), fatigue, and non-restorative sleep. Red flags like weight loss, fever, or elevated ESR/CRP suggest an alternative inflammatory etiology.
Diagnosis
Diagnosis is clinical; no specific lab or imaging confirms the disease. Use the Widespread Pain Index (WPI) and Symptom Severity (SS) scale to quantify symptoms. Must rule out hypothyroidism and rheumatoid arthritis with TSH and ESR/CRP.
Treatment
First-line therapy is Pregabalin or Duloxetine. Avoid opioids and corticosteroids as they are ineffective and may worsen hyperalgesia. Aerobic exercise and cognitive behavioral therapy (CBT) are essential adjuncts for long-term management.
Prognosis
Chronic, relapsing course with no mortality increase. Multidisciplinary approach is required to prevent disability and maintain quality of life.
Differential Diagnosis
Polymyalgia rheumatica: elevated ESR/CRP and age >50
Rheumatoid arthritis: joint swelling and erosive changes on imaging
Hypothyroidism: abnormal TSH and cold intolerance
Systemic lupus erythematosus: positive ANA and multisystem involvement
Myofascial pain syndrome: localized trigger points rather than widespread pain